Biomarkers of Basic Activities of Daily Living in Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2012-07-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/JAD-2012-111481PMID 22571981PMCID PMC3644945
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Feed‐forward hierarchical model of the ventral visual stream applied to functional brain image classification

  2014cited by this paper
• Biomarkers and Depressive Symptoms in Older Women with and without Cognitive Impairment

  2012cited by this paper
• Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy.

  2011cited by this paper
• Longitudinal change of biomarkers in cognitive decline.

  2011cited by this paper
• Alzheimer's disease: implications of the updated diagnostic and research criteria.

  2011cited by this paper
• Dependence and Caregiver Burden in Alzheimer’s Disease and Mild Cognitive Impairment

  2011cited by this paper
• Biomarkers and Depressive Symptoms in a Sample of Cognitively Intact and Alzheimer’s Disease Elderly Males

  2011cited by this paper
• Discovery of Sexual Dimorphisms in Metabolic and Genetic Biomarkers

  2011cited by this paper
• Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.

  2011cited by this paper
• Interleukin-15 regulates proliferation and self-renewal of adult neural stem cells

  2011cited by this paper
• The Link between Cognitive Measures and ADLs and IADL Functioning in Mild Alzheimer's: What Has Gender Got to Do with It?

  2011cited by this paper
• P2‐057: Aβ blood levels and Alzheimer's disease.

  2011influential reference
• Association between circulating hemostatic measures and dementia or cognitive impairment: systematic review and meta‐analyzes

  2011cited by this paper
• A Blood-Based Algorithm for the Detection of Alzheimer’s Disease

  2011cited by this paper
• Identification of peripheral inflammatory markers between normal control and Alzheimer's disease

  2011cited by this paper
• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• A serum protein-based algorithm for the detection of Alzheimer disease.

  2010cited by this paper
• A meta-analysis of cytokines in Alzheimer's disease.

  2010cited by this paper
• Biomarker discovery for Alzheimer’s disease, frontotemporal lobar degeneration, and Parkinson’s disease

  2010cited by this paper
• Differential Activation of Tumor Necrosis Factor Receptors Distinguishes between Brains from Alzheimer's Disease and Non-Demented Patients

  2010cited by this paper
• Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment.

  2010cited by this paper
• Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease.

  2010cited by this paper
• Decreased C-Reactive Protein Levels in Alzheimer Disease

  2010cited by this paper
• The role of proteomics in dementia and Alzheimer’s disease

  2009cited by this paper
• Is there a relationship between high C-reactive protein (CRP) levels and dementia?

  2009cited by this paper
• Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment

  2008cited by this paper
• Cytokines and Myelination in the Central Nervous System

  2008cited by this paper
• Serum Brain-Derived Neurotrophic Factor Is Associated With Cognitive Function in Healthy Older Adults

  2008cited by this paper
• Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease. The Rotterdam Study.

  2008cited by this paper
• Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.

  2008cited by this paper
• High interleukin‐6 plasma levels are associated with functional impairment in older patients with Vascular dementia

  2007cited by this paper
• A Novel Panel of Cerebrospinal Fluid Biomarkers for the Differential Diagnosis of Alzheimer’s Disease versus Normal Aging and Frontotemporal Dementia

  2007cited by this paper
• Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment

  2007cited by this paper
• アルツハイマー病の早期診断に向けて-米国 Alzheimer's Disease Neuroimaging Initiative の取り組み

  2006cited by this paper
• Neuropathologic Correlates of Activities of Daily Living in Alzheimer Disease

  2006cited by this paper
• Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease.

  2005cited by this paper
• Extracellular matrix components associated with remodeling processes in brain

  2004cited by this paper
• Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia.

  2003cited by this paper
• Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.

  2001cited by this paper
• Strategies for Driving Cessation in Alzheimer Disease

  1997cited by this paper
• Assessing functioning and self-care abilities in Alzheimer disease research.

  1997influential reference
• Assessing Alzheimer Severity With a Global Clinical Scale

  1992cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Assessment of older people: self-maintaining and instrumental activities of daily living.

  1969cited by this paper

• Brain interleukins and Alzheimer’s disease

  2025cites this paper
• APOE ε4–associated downregulation of the IL‐7/IL‐7R pathway in effector memory T cells: Implications for Alzheimer's disease

  2024cites this paper
• Interleukin-17 (IL-17) triggers systemic inflammation, peripheral vascular dysfunction, and related prothrombotic state in a mouse model of Alzheimer's disease.

  2022cites this paper
• The Role of Tenascin-C in Tissue Injury and Repair After Stroke

  2021cites this paper
• Peripheral sTREM2-Related Inflammatory Activity Alterations in Early-Stage Alzheimer’s Disease

  2021cites this paper
• Accelerated Ovarian Failure as a Unique Model to Study Peri-Menopause Influence on Alzheimer’s Disease

  2019cites this paper
• Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study

  2017cites this paper
• IL-7 and Depression: The importance of gender and blood fraction.

  2016cites this paper
• Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.

  2016cites this paper
• Cholesterol Diet-Associated Changes in the Hippocampus - A Prelude to Alzheimer's Disease?

  2016cites this paper
• CALIFORNIA STATE UNIVERSITY, NORTHRIDGE FUNCTIONAL DEFICITS IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE

  2015cites this paper
• Serum Interleukin (IL)-15 as a Biomarker of Alzheimer's Disease

  2015cites this paper
• The Impact of APOE Status on Relationship of Biomarkers of Vascular Risk and Systemic Inflammation to Neuropsychiatric Symptoms in Alzheimer's Disease

  2014cites this paper
• Prognostic Polypeptide Blood Plasma Biomarkers of Alzheimer's Disease Progression

  2014cites this paper
• Astrocyte-Secreted Matricellular Proteins in CNS Remodelling during Development and Disease

  2014cites this paper
• Biomarkers of Vascular Risk, Systemic Inflammation, and Microvascular Pathology and Neuropsychiatric Symptoms in Alzheimer's Disease

  2013influential citation